Stock Track | Tempus AI Soars 5% in Pre-Market on Acquisition and Growth Prospects

Stock Track

Feb 13, 2025

Shares of Tempus AI (TEM) surged 5.09% in Thursday's pre-market trading session, buoyed by the company's recent moves to expand its healthcare offerings and optimism around its AI-driven solutions.

The AI healthcare company recently completed the acquisition of Ambry Genetics, enabling it to offer more comprehensive cancer screening and expand into other areas like pediatrics, reproductive health, and immunology. Additionally, Tempus AI announced a collaboration with the Institute for Follicular Lymphoma Innovation (IFLI) to develop a data library and AI-driven insights aimed at accelerating the development of treatments for follicular lymphoma.

These strategic initiatives, combined with management's projection of strong revenue growth for 2024, have fueled investor enthusiasm for Tempus AI's prospects. As the company continues to leverage its AI capabilities to drive innovation in precision medicine and patient care, the market appears optimistic about its potential to capture a significant share of the burgeoning AI healthcare market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1136388238"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1136388238\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1136388238?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-13 22:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1136388238","market":"us","top_or_hot":-1,"title":"Stock Track | Tempus AI Soars 5% in Pre-Market on Acquisition and Growth Prospects","media":"Stock Track","content":"<p>Shares of Tempus AI (TEM) surged 5.09% in Thursday's pre-market trading session, buoyed by the company's recent moves to expand its healthcare offerings and optimism around its AI-driven solutions.</p>\n\n<p>The AI healthcare company recently completed the acquisition of Ambry Genetics, enabling it to offer more comprehensive cancer screening and expand into other areas like pediatrics, reproductive health, and immunology. Additionally, Tempus AI announced a collaboration with the Institute for Follicular Lymphoma Innovation (IFLI) to develop a data library and AI-driven insights aimed at accelerating the development of treatments for follicular lymphoma.</p>\n\n<p>These strategic initiatives, combined with management's projection of strong revenue growth for 2024, have fueled investor enthusiasm for Tempus AI's prospects. As the company continues to leverage its AI capabilities to drive innovation in precision medicine and patient care, the market appears optimistic about its potential to capture a significant share of the burgeoning AI healthcare market.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tempus AI Soars 5% in Pre-Market on Acquisition and Growth Prospects</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tempus AI Soars 5% in Pre-Market on Acquisition and Growth Prospects\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-13 22:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Tempus AI (TEM) surged 5.09% in Thursday's pre-market trading session, buoyed by the company's recent moves to expand its healthcare offerings and optimism around its AI-driven solutions.</p>\n\n<p>The AI healthcare company recently completed the acquisition of Ambry Genetics, enabling it to offer more comprehensive cancer screening and expand into other areas like pediatrics, reproductive health, and immunology. Additionally, Tempus AI announced a collaboration with the Institute for Follicular Lymphoma Innovation (IFLI) to develop a data library and AI-driven insights aimed at accelerating the development of treatments for follicular lymphoma.</p>\n\n<p>These strategic initiatives, combined with management's projection of strong revenue growth for 2024, have fueled investor enthusiasm for Tempus AI's prospects. As the company continues to leverage its AI capabilities to drive innovation in precision medicine and patient care, the market appears optimistic about its potential to capture a significant share of the burgeoning AI healthcare market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TEM","symbol_name":"Tempus AI","start_time":0,"source_url":"","article_id":"1136388238","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1136388238","pubTimestamp":1739456439,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Tempus AI  surged 5.09% in Thursday's pre-market trading session, buoyed by the company's recent moves to expand its healthcare offerings and optimism around its AI-driven solutions.The AI healthcare company recently completed the acquisition of Ambry Genetics, enabling it to offer more comprehensive cancer screening and expand into other areas like pediatrics, reproductive health, and immunology. Additionally, Tempus AI announced a collaboration with the Institute for Follicular Lymph","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TEM":"Tempus AI"},"translate_title":"股票赛道Tempus AI因收购和增长前景盘前飙升5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEM":1},"content_text":"Shares of Tempus AI (TEM) surged 5.09% in Thursday's pre-market trading session, buoyed by the company's recent moves to expand its healthcare offerings and optimism around its AI-driven solutions.\nThe AI healthcare company recently completed the acquisition of Ambry Genetics, enabling it to offer more comprehensive cancer screening and expand into other areas like pediatrics, reproductive health, and immunology. Additionally, Tempus AI announced a collaboration with the Institute for Follicular Lymphoma Innovation (IFLI) to develop a data library and AI-driven insights aimed at accelerating the development of treatments for follicular lymphoma.\nThese strategic initiatives, combined with management's projection of strong revenue growth for 2024, have fueled investor enthusiasm for Tempus AI's prospects. As the company continues to leverage its AI capabilities to drive innovation in precision medicine and patient care, the market appears optimistic about its potential to capture a significant share of the burgeoning AI healthcare market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"merge,movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}